NewsPress Releases
Louvain-la-Neuve, 14th January 2025 Minakem has been manufacturing the Fulvestrant Active Pharmaceutical Ingredient (API), used to treat certain types of breast cancer, for more than 10 years. The original process…
NewsPress Releases
Louvain-la-Neuve, 14th January 2025 Minakem has been manufacturing the Fulvestrant Active Pharmaceutical Ingredient (API), used to treat certain types of breast cancer, for more than 10 years. The original process…